Can a 'Love Hormone' spray tame Prader-Willi symptoms?
NCT ID NCT02804373
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether oxytocin nasal spray, sometimes called the 'love hormone,' can improve behavior and eating problems in adults with Prader-Willi syndrome. Fifty participants received either oxytocin or a placebo daily or every three days for 28 days. Researchers measured changes in behavior, eating habits, and brain activity using scans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oxytocin nasal spray
- What this could lead to
- If it works, this could offer a new way to ease behavioral and eating problems in Prader-Willi syndrome, improving social function and quality of life.
- What could go wrong
- This is a small, completed Phase 2/3 trial. Results may not be strong enough to confirm benefit, and oxytocin may not work for everyone or could have side effects like nasal irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRADER-WILLI SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre de référence Prader-Willi - Hôpital Purpan
Toulouse, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can early parent coaching help infants with rare genetic disorders thrive?
- Newborn screening study aims to catch rare diseases at birth
- Brain and eye clues to emotion recognition in autism and psychosis
- New group therapy aims to tame meltdowns in Prader-Willi teens
- CBDV study for Prader-Willi syndrome halted early
- Can a light box beat daytime sleepiness in Prader-Willi?